Safety of Dengue Vaccine?

por Biswal, Shibadas, Patel, Sanjay S, Rauscher, Martina
Publicado 2022

97. Tetravalent Dengue Vaccine (TAK-003) Development Program: A Bird’s Eye View

por Tricou, Vianney, Biswal, Shibadas, Liu, Mengya, Patel, Sanjay S, Zent, Olaf, Rauscher, Martina, Perez, Gonzalo, Kandeil, Walid, Folschweiller, Nicolas
Publicado 2021

Effect of the Tetravalent Dengue Vaccine TAK-003 on Sequential Episodes of Symptomatic Dengue

por Sáez-Llorens, Xavier, Biswal, Shibadas, Borja-Tabora, Charissa, Fernando, LakKumar, Liu, Mengya, Wallace, Derek, Folschweiller, Nicolas, Reynales, Humberto, LeFevre, Inge
Publicado 2023

Bridging the immunogenicity of a tetravalent dengue vaccine (TAK-003) from children and adolescents to adults

por LeFevre, Inge, Bravo, Lulu, Folschweiller, Nicolas, Medina, Eduardo Lopez, Moreira, Edson Duarte, Nordio, Francesco, Sharma, Mayuri, Tharenos, Leslie M., Tricou, Vianney, Watanaveeradej, Veerachai, Winkle, Peter J., Biswal, Shibadas
Publicado 2023

Immunogenicity and safety of a tetravalent dengue vaccine in dengue-naïve adolescents in Mexico City

por Biswal, Shibadas, Mendez Galvan, Jorge Fernando, Macias Parra, Mercedes, Galan-Herrera, Juan-Francisco, Carrascal Rodriguez, Monica Belisa, Rodriguez Bueno, Esteban Patricio, Brose, Manja, Rauscher, Martina, LeFevre, Inge, Wallace, Derek, Borkowski, Astrid
Publicado 2021

Three-year Efficacy and Safety of Takeda’s Dengue Vaccine Candidate (TAK-003)

por Rivera, Luis, Biswal, Shibadas, Sáez-Llorens, Xavier, Reynales, Humberto, López-Medina, Eduardo, Borja-Tabora, Charissa, Bravo, Lulu, Sirivichayakul, Chukiat, Kosalaraksa, Pope, Martinez Vargas, Luis, Yu, Delia, Watanaveeradej, Veerachai, Espinoza, Felix, Dietze, Reynaldo, Fernando, LakKumar, Wickramasinghe, Pujitha, Duarte MoreiraJr, Edson, Fernando, Asvini D, Gunasekera, Dulanie, Luz, Kleber, Venâncioda Cunha, Rivaldo, Rauscher, Martina, Zent, Olaf, Liu, Mengya, Hoffman, Elaine, LeFevre, Inge, Tricou, Vianney, Wallace, Derek, Alera, MariaTheresa, Borkowski, Astrid
Publicado 2021

Efficacy of a Dengue Vaccine Candidate (TAK-003) in Healthy Children and Adolescents 2 Years after Vaccination

por López-Medina, Eduardo, Biswal, Shibadas, Saez-Llorens, Xavier, Borja-Tabora, Charissa, Bravo, Lulu, Sirivichayakul, Chukiat, Vargas, Luis Martinez, Alera, Maria Theresa, Velásquez, Hector, Reynales, Humberto, Rivera, Luis, Watanaveeradej, Veerachai, Rodriguez-Arenales, Edith Johana, Yu, Delia, Espinoza, Felix, Dietze, Reynaldo, Fernando, Lak Kumar, Wickramasinghe, Pujitha, Duarte Moreira, Edson, Fernando, Asvini D, Gunasekera, Dulanie, Luz, Kleber, da Cunha, Rivaldo Venâncio, Tricou, Vianney, Rauscher, Martina, Liu, Mengya, LeFevre, Inge, Wallace, Derek, Kosalaraksa, Pope, Borkowski, Astrid
Publicado 2020